26 results
PRE 14A
PRME
Prime Medicine Inc
19 Apr 24
Preliminary proxy
4:07pm
Oversight Process
Our Board has an active role, as a whole and also at the committee level, in overseeing the management of our risks. Our Board … is responsible for general oversight of risks and regular review of information regarding our risks, including credit risks, liquidity risks, operational
8-K
EX-1.1
PRME
Prime Medicine Inc
16 Feb 24
Entry into a Material Definitive Agreement
6:23am
subsidiaries within the applicable rules and regulations adopted by the Commission and the Public Company Accounting Oversight Board (United States … protection controls, policies and procedures, including oversight, access controls, encryption, technological and physical safeguards and business
424B5
PRME
Prime Medicine Inc
16 Feb 24
Prospectus supplement for primary offering
6:17am
compliance with the requirements of the Public Company Accounting Oversight Board regarding the communication of critical audit matters in the auditor’s
424B5
xl45tah1ys4qmelnqj
14 Feb 24
Prospectus supplement for primary offering
5:27pm
S-3
EX-1.2
xm3x3f qm7llp
3 Nov 23
Shelf registration
5:23pm
S-3
khmg5796n3xbddcaqf7
3 Nov 23
Shelf registration
5:23pm
DEF 14A
zrs5ue
28 Apr 23
Definitive proxy
8:34am
10-Q
mj7ahoo6z00u9n
14 Nov 22
Quarterly report
4:46pm
424B4
1ix8mp zacey
21 Oct 22
Prospectus supplement with pricing info
4:47pm
S-1/A
jdagpqn0ho 8j4qk9
13 Oct 22
IPO registration (amended)
10:51am
S-1
6h9bwr0d
23 Sep 22
IPO registration
4:12pm
S-1
EX-1.1
m10uxvr9ila02dcb my1
23 Sep 22
IPO registration
4:12pm
S-1
EX-10.13
92gghaw7wmw4ok4sb
23 Sep 22
IPO registration
4:12pm
DRS/A
qrdtkz
5 Aug 22
Draft registration statement (amended)
12:00am
DRS/A
rrpuncca
6 May 22
Draft registration statement (amended)
12:00am